Clinical genomics

Rare Disease Genomics

Phenotype-driven next-generation sequencing across rare-disease domains.

Rare-disease testing begins with the clinical phenotype. A phenotype-driven panel, or a broader genome-scale approach where the presentation is non-specific, is selected in consultation with the referring clinician and interpreted against the documented clinical findings.

Documented capability

  • A catalogue of phenotype-driven NGS panels spanning neurological, neuromuscular, cardiovascular, immunological, renal, endocrine, metabolic, dermatological, skeletal, ophthalmic, auditory and multisystem indications
  • Selection of panel breadth according to the clinical question
  • Variant interpretation against detailed clinical phenotype
  • Orthogonal confirmation and family segregation studies where indicated

Panel names, gene counts and gene content in the catalogue are reproduced from the department’s current NGS panel source document. Panel composition may be revised; the version in force at the time of testing applies.

This page is informational. It does not accept requests, samples, patient data or genomic files, and provides no result lookup.

Rare disease panels in the catalogue

Genetic Panel Search

54 panels. Panel names, gene counts and gene lists are reproduced from the department’s current NGS panel source document. Panel composition may be revised; the version in force at the time of testing applies.

Metabolic & Mitochondrial

Neurology & Neurodevelopment

Neuromuscular

Cardiovascular

Immunology & Autoinflammatory

Hematology & Bone Marrow Failure

Endocrine & Metabolic Endocrinology

Renal

Respiratory

Dermatology

Ophthalmology & Hearing

Skeletal & Connective Tissue

Syndromic & Multisystem